Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify Prostate Cancer Osteonosus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify Prostate Cancer Osteonosus
Authors
Keywords
-
Journal
Journal of Healthcare Engineering
Volume 2021, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2021-12-11
DOI
10.1155/2021/7380120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
- (2020) Mohsen Beheshti et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer
- (2020) David C. Smith et al. Clinical Genitourinary Cancer
- Prostate-specific membrane antigen theranostics in advanced prostate cancer: an evolving option
- (2020) Nikhil Mayor et al. BJU INTERNATIONAL
- Nuclear medicine and molecular imaging advances in the 21st century
- (2020) Sofia C. Vaz et al. BRITISH JOURNAL OF RADIOLOGY
- Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer
- (2020) Aravind S. Ravi Kumar et al. CURRENT OPINION IN UROLOGY
- Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
- (2020) Shobhana Raju et al. NUCLEAR MEDICINE COMMUNICATIONS
- Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer
- (2020) Xiuqin Song et al. Experimental and Therapeutic Medicine
- Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
- (2020) Pedro Barata et al. Journal for ImmunoTherapy of Cancer
- Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization
- (2020) Li Tang et al. Annals of Palliative Medicine
- Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
- (2020) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
- (2020) Claire L Vale et al. LANCET
- Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
- (2019) Xiangyu Zhang Cancer Communications
- SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma
- (2018) Tingru Shao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
- (2018) Liselotte M.S. Boevé et al. EUROPEAN UROLOGY
- Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases
- (2018) Lavinia Vija Racaru et al. NUCLEAR MEDICINE COMMUNICATIONS
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search